Mongolian Journal of Health Sciences 2025;88(4):47-51
Impact of Individual Temperament on the Immune Response After COVID-19 Vaccination
Burenjargal B 1 ; Dashpagam O 2 ; Shatar Sh 3 ; Khongorzul T 4 ; Ariunzaya B 4 ; Zolmunkh N 4 ; Gansukh Ch 4 ; Ulziisaikhan B 4 ; Chimidtseren S 4 ; Baasanjargal B 5 ; Enkh-Amar B 4 ; Nomin-Erdene Ts 4 ; Davaalkham D 3 ; Tsogtsaikhan S 4 ; Batbaatar G 4
Affiliations
Keywords
Temperament; COVID-19 vaccine; Immune response; Antibody; Personality traits
Country
Mongolia
Language
Mongolian
Abstract
Background: The first confirmed case of COVID-19 in Mongolia was reported on November 11, 2020. In response, the
government imposed a nationwide lockdown, which significantly impacted the population’s mental health. Heightened
levels of stress, anxiety, loneliness, and depression during the pandemic altered individuals’ psychological stability and
behavior. Personality traits—defined as relatively stable patterns of emotion, cognition, and behavior—play a key role in
stress responses and emotional regulation under pressure. Emerging evidence suggests that these psychological factors
may influence the immune system’s responsiveness, including vaccine-induced antibody production.
Aim:To evaluate the association between post-vaccination antibody responses and personality types following two doses
of COVID-19 vaccines.
Materials and Methods:A total of 738 participants who received two doses of COVID-19 vaccines (AstraZeneca
ChAdOx1, n=29; Pfizer-BioNTech, n=119; Sinopharm BBIBP, n=590) and had no prior SARS-CoV-2 infection were enrolled. Serum samples were collected 21–28 days after the second dose, and SARS-CoV-2 RBD (S) IgG antibodies
were measured using ELISA (Proteintech Inc., USA). Personality types were assessed using a 56-item temperament
questionnaire developed by A. Belov, categorizing individuals into classical temperament types (choleric, phlegmatic,
sanguine, melancholic). Logistic regression and ROC analysis were used to examine associations between personality
types and antibody response.
Results:The presence of an antibody response was significantly higher among individuals with a melancholic temperament, and significantly lower among those with a phlegmatic temperament. Furthermore, antibody titers were higher in
participants with melancholic and sanguine temperaments and lower in those with a phlegmatic type.
Conclusions:1. During the early period following the second dose of COVID-19 vaccination, the antibody response was higher in individuals with a pure melancholic temperament, while it was lower in those with a phlegmatic temperament. 2. After the second dose of the Sinopharm BBIBP COVID-19 vaccine, antibody titers were higher in individuals with pure melancholic and sanguine temperaments, and lower in those with a phlegmatic temperament.
备案号: 11010502037788, 京ICP备10218182号-8)